Invention Grant
- Patent Title: Pathway analysis for identification of diagnostic tests
-
Application No.: US14320214Application Date: 2014-06-30
-
Publication No.: US11011273B2Publication Date: 2021-05-18
- Inventor: Stephen Charles Benz , Shahrooz Rabizadeh , Christopher Szeto , Paul Weingarten , Chunlin Tao
- Applicant: Nantomics, LLC
- Applicant Address: US CA Culver City
- Assignee: Nantomics, LLC
- Current Assignee: Nantomics, LLC
- Current Assignee Address: US CA Culver City
- Agency: Umberg Zipser LLP
- Agent Martin Fessenmaier
- Main IPC: G16H50/20
- IPC: G16H50/20 ; C07D403/14 ; C07D403/12 ; A61P35/00 ; A61K31/506 ; C07D401/14 ; C07D417/14 ; C07D413/14

Abstract:
The present inventive subject matter provides apparatus, systems, and methods in which a diagnostic test is identified, where the diagnostic test is for determining whether a particular treatment is effective for a particular patient based on one or more characteristics of a patient's cells. When a treatment is developed with the potential to treat one or more diseases, the drug can have different effects on different cell lines related to the diseases. A machine learning system is programmed to infer a measurable cell characteristic, out of many different measurable cell characteristics, that has a desirable correlation with the sensitivity data of different cell lines to a treatment. The machine learning system is programmed to then determine, based on the correlation, a threshold level of the cell characteristic the patient should exhibit in order to recommend administering the treatment.
Public/Granted literature
- US20150006445A1 PATHWAY ANALYSIS FOR IDENTIFICATION OF DIAGNOSTIC TESTS Public/Granted day:2015-01-01
Information query